Navigation Links
Parkinson's Drugs Can Trigger Unhealthy Behaviors
Date:4/10/2009

But lower doses of dopamine agonists appear to curb compulsive acting out, study says

FRIDAY, April 10 (HealthDay News) -- A class of Parkinson's disease drugs called dopamine agonists can cause patients to develop destructive behaviors such as compulsive gambling or hypersexuality, says a new study.

Mayo Clinic researchers found that one in six patients taking therapeutic doses of dopamine agonists, such as pramipexole and ropinirole, developed unhealthy behaviors. But decreasing the dosage of these drugs may eliminate the problem.

For their study, the researchers analyzed the medical records of 267 Parkinson's disease patients treated at the Mayo Clinic in Rochester, Minn., between 2004 and 2006. Of those patients, 66 were taking dopamine agonists, including 38 who were taking therapeutic doses (doses expected to be at least minimally beneficial).

Seven of the 38 patients taking therapeutic doses of dopamine agonists developed compulsive gambling or hypersexuality after they started taking the drugs. None of the other Parkinson's patients developed those destructive behaviors, including the 28 patients taking subtherapeutic doses of dopamine agonists, or the 178 patients taking carbidopa/levodopa, the standard drug for Parkinson's.

The study is published in the April issue of Mayo Clinic Proceedings.

"It is crucial for clinicians prescribing dopamine agonists to apprise patients as well as their spouses or partners about this potential side effect. The onset can be insidious and overlooked until life-altering problems develop," Dr. J. Eric Ahlskog, a Mayo Clinic neurologist, said in a clinic news release. "It also is worth noting that the affected patients were all taking therapeutic doses. Very low doses, such as those used to treat restless legs syndrome, carry much less risk."

"For some patients, a reduction in the dose of the dopamine agonist may prove to be sufficient treatment, although total elimination of the offending drug is often necessary," Ahlskog added.

More information

We Move has more about treatments for Parkinson's disease.



-- Robert Preidt



SOURCE: Mayo Clinic, news release, April 8, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Test quickly assesses whether Alzheimers drugs are hitting their target
2. Patient Movement Forms in Opposition to FDA Position that the Patient's Own Stem Cells are Drugs
3. Private-label OTC Drugs Post Solid Gains in 2008, According to Kline
4. Certain Diabetes Drugs May Pose Eye Risk
5. Breakthrough model for human cancer may improve development of cancer drugs; study in PNAS
6. More U.S. Kids Taking Diabetes, Blood Pressure Drugs
7. Link between widely used osteoporosis drugs and heart problems probed
8. Interviewed Experts Expect Taxotere to Increase Overall Survival More Than Other Drugs, Including Lupron Depot, in Stage III Prostate Cancer
9. Researchers question effectiveness of warning labels on over-the-counter drugs
10. Patients Say MPM Medicals Regenecare Gel Significantly Reduced the Itching and Pain of Skin Rashes Triggered by Anti-Cancer Drugs
11. IROs Help Decide Medically on Approved Uses of Off-Label Drugs for Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Parkinson's Drugs Can Trigger Unhealthy Behaviors
(Date:2/17/2017)... , ... February 17, 2017 , ... ... brings its educational assistance management solution to the exhibit floor for the ... Orlando, Fla. , From Feb. 19–23, 2017, more than 40,000 healthcare industry ...
(Date:2/17/2017)... , ... February 17, 2017 , ... ... Dr. Carol Francis' goals for each and every seminar, session and ... Francis will demonstrate five different brainwave tools which help energize creativity, focus mental ...
(Date:2/17/2017)... ... 2017 , ... Qualis Health, one of the nation's leading ... DecisionHealth Platinum Awards in recognition of its innovative healthcare management programs that are ... award categories, highlighting four of the organization’s current programs:, , ...
(Date:2/17/2017)... WASHINGTON (PRWEB) , ... February 17, 2017 , ... ... communities by fall 2017 season , Trinity Health and the U.S. Soccer Foundation ... for Success program in underserved communities. Soccer for Success, the Foundation’s soccer mentoring ...
(Date:2/17/2017)... ... February 17, 2017 , ... Pharmica Consulting attended CHI's 8th ... of clinical trial planning and management. Pharmica discussed the importance of effective project ... attendees stopping by Pharmica’s booth were able to demo its cloud-based Resource ...
Breaking Medicine News(10 mins):
(Date:2/16/2017)... , Feb. 16, 2017 Research ... Markets for Emerging Medical Device Technologies" report to their ... ... valves, open procedures, general instruments, non-drug coated implantables, large endoscopes, ... been in use over the last two to three decades ...
(Date:2/16/2017)... Feb. 16, 2017  Aralez Pharmaceuticals Inc. (NASDAQ: ... company, today announced that executive management will participate in ... held February 22-23, 2017. Adrian Adams , Chief ... at 1:35 p.m. local time on Wednesday, February 22, ... for the event may be accessed from the Investors ...
(Date:2/16/2017)... , Feb. 16, 2017  AcelRx Pharmaceuticals, Inc. ... company focused on the development and commercialization of ... pain, announced that Vincent J. Angotti ... member of the company,s board of directors, effective ... two decades of experience leading executive and commercial ...
Breaking Medicine Technology: